Clinical evaluation demonstrates strong consistency between multi-echo Dixon MRI and magnetic resonance spectroscopy in non-alcoholic fatty liver disease, indicating reliable monitoring of liver fat.
ME-Dixon has a good consistency and a correlation with MRS in quantifying the liver fat content and monitoring the treatment effect, which may be used as an accurate indicator for clinical monitoring of changes in the liver fat content.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: